Toggle navigation
Home
Search
Services
Blog
Contact
About
In Vivo Effects of Apolipoprotein Ai Variants on Hdl
,
Lawrence Berkeley National Laboratory, Berkeley, CA, United States
Search grants from
Search grants from Lawrence Berkeley National Laboratory
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Parent-Child Biobehavioral Coregulation and Child Maltreatment Risk
Poly(ADP-ribose) polymerase in diabetic nephropathy
Workshops and Dissemination
Modulation of Glomerular Ultrafiltration Coefficient
Blood and Blood Diseases
Recently added grants:
The Roles of LPS-Binding Protein Vascular Peroxidase-1 in Innate Immunity
Exploiting Diversity-Oriented Chemical Synthesis for Combating Chronic Parasitic Infection
Age-dependent susceptibility to infection
Mechanisms of R loop-mediated genome instability in Wiskott-Aldrich syndrome
The biofilm matrix of P. aeruginosa
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32HL008802-01
Application #
2213616
Study Section
Biological Sciences 2 (BIOL)
Project Start
1993-03-29
Project End
Budget Start
1992-09-30
Budget End
1994-02-28
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Institution
Name
Lawrence Berkeley National Laboratory
Department
Radiation-Diagnostic/Oncology
Type
Organized Research Units
DUNS #
078576738
City
Berkeley
State
CA
Country
United States
Zip Code
94720
Related projects
NIH 1994
F32 HL
In Vivo Effects of Apolipoprotein Ai Variants on Hdl
/ Lawrence Berkeley National Laboratory
NIH 1992
F32 HL
In Vivo Effects of Apolipoprotein Ai Variants on Hdl
/ Lawrence Berkeley National Laboratory
Publications
ElSawy, Mahmoud; Storer, Barry E; Sorror, Mohamed L
(2014)
""To combine or not to combine"": optimizing risk assessment before allogeneic hematopoietic cell transplantation.
Biol Blood Marrow Transplant 20:1455-6
Comments
Be the first to comment on this grant